An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Principal Investigator
John SwistonOverview
Study Start/End
Jul 31, 2017 to Dec 31, 2021Locations
Diamond Health Care CentreName/Title
Mami Okada, Research CoordinatorPhone
604-875-4111 ext.69831Email Address
mami.okada@vch.caPurpose of Study
This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with pulmonary hypertension (PH) who previously participated in controlled clinical studies with bardoxolone methyl.
Eligibility
Please see Clinicaltrials.gov
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.